Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yogesh Patel

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 2, 2025
Epidemiology of malaria in Chhattisgarh, India: a surveillance data analysis, 2015-2023Dharmendra Kumar Gahwai, Mogan Kaviprawin, Gollapalli Pavan Kumar, et al.
Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine|December 26, 2025
Assessing the Role of Pradhan Mantri TB Mukt Bharat Abhiyaan in India's Fight against TB: A National-level Data-based Research InvestigationHarsh Shah, Jay Patel, Raghuram Rao, et al.
Molecular Cancer Therapeutics|June 16, 2022
Combination of Ribociclib and Gemcitabine for the Treatment of MedulloblastomaAllison Pribnow, Barbara Jonchere, Jingjing Liu, et al.
European Heart Journal|October 23, 2014
Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessmentJeremiah P Depta, Jayendrakumar S Patel, Eric Novak, et al.
Blood|December 19, 2024
Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVHAustin Kulasekararaj, Morag Griffin, Caroline Piatek, et al.
Annals of Hematology|January 22, 2025
Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuriaAustin Kulasekararaj, Robert Brodsky, Hubert Schrezenmeier, et al.
BMJ Open|October 9, 2024
Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 studyThomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 2, 2025
Epidemiology of malaria in Chhattisgarh, India: a surveillance data analysis, 2015-2023Dharmendra Kumar Gahwai, Mogan Kaviprawin, Gollapalli Pavan Kumar, et al.
Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine|December 26, 2025
Assessing the Role of Pradhan Mantri TB Mukt Bharat Abhiyaan in India's Fight against TB: A National-level Data-based Research InvestigationHarsh Shah, Jay Patel, Raghuram Rao, et al.
Molecular Cancer Therapeutics|June 16, 2022
Combination of Ribociclib and Gemcitabine for the Treatment of MedulloblastomaAllison Pribnow, Barbara Jonchere, Jingjing Liu, et al.
European Heart Journal|October 23, 2014
Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessmentJeremiah P Depta, Jayendrakumar S Patel, Eric Novak, et al.
Blood|December 19, 2024
Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVHAustin Kulasekararaj, Morag Griffin, Caroline Piatek, et al.
Annals of Hematology|January 22, 2025
Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuriaAustin Kulasekararaj, Robert Brodsky, Hubert Schrezenmeier, et al.
BMJ Open|October 9, 2024
Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 studyThomas D Norton, Mazhar Thakur, Samit Ganguly, et al.
Pageof 8